Several studies have shown that stereotactic brachytherapy with iodine-125 seeds is an elective treatment of brain tumors as well as brain metastasis (cf. Brainstorm 1 / 2016, 125 Jod-Brachytherapie zur Behandlung von Hirntumoren: ein Follow-Up, ed. Deutsche Hirntumorhilfe e.V.). Using low dose schemes has sophisticated the seed treatment significantly making it save and a valuable addition to surgery, chemotherapy and other radiation treatments for select patients.

IsoSeed® for Brain Tumor Treatment is offered as I25.S17plus with nine activity classes determined for an effective stereotactic treatment. The loose seeds are supplied sterile in a shielded stainless steel container and therefore ready for use. Eckert & Ziegler BEBIG´s long record in manufacturing seeds combined with fast product delivery, make IsoSeed® I25.S17plus for Brain Tumor Treatment a valuable portfolio addition.